RA patient PD-1+ B cells had higher activation of the AKT/mTOR/S6 pathway, leading to increased GLUT1 expression and glucose uptake under normoxic and hypoxic conditions compared with PD-1– counterparts. This evidence concerns the gene SLC2A1 and rheumatoid arthritis.